跳至主要内容
临床试验/JPRN-UMIN000016442
JPRN-UMIN000016442已完成未知

A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating. - A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating.

Izumo-City General Medical Center0 个研究点目标入组 80 人开始时间: 2015年2月4日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients receiving daikenchuto or other Japanese traditional herbal medicine within 4 weeks before enrolled in this study If not stable doses of the follow medications are taken for at least 2 weeks before enrolled to this study: acid suppressant, prokinetics, calcium polycarbophil, anticholinergic drug, laxative, antidepressant, anti-anxiety agent. Patients with organic lesion like cancer. Patients with serious coexisting disease (e.g. Hepatic, renal, cardiac, hematological, or metabolic disorder). Lactating or pregnant mother or women who wish to become pregnant during the study period. Determined not applicable for this study by the investigator.

研究者

发起方
Izumo-City General Medical Center

相似试验